Mitzi Donaldson,;
SUPER stock pick for you Today!!!
CSJJ - CSJJ in Negotiations to Acquire 35% in BioMedicom Inc - stock is set to
go crazy on
Thursday
CSJJ - This is stock GEM.. its great buy below 5-7 cents and huge profits could
be made with
CSJJ because it is lower priced stock so it can go up not only a few percent
but a few hundred or
thousand %.
BREAKING NEWS -> JUMP ON BOARD TODAY + HUGE PROFITS EXPECTED
CSJJ in Negotiations to Acquire 35% in BioMedicom Inc
We believe that the SPECULATIVE NEAR TERM TARGET PRICE for next 3 days - $0.12
We believe that the SPECULATIVE NEAR TERM TARGET PRICE for next 5 days - $0.19
>>>>>>>>> CSJJ CSJJ CSJJ CSJJ CSJJ <<<<<<<<<<<
Trading Alert
Coastal Holdings, Inc.
Symbol: SCJJ
Current Price: $0.028
We believe that the SPECULATIVE NEAR TERM TARGET PRICE for next 3 days - $0.12
We believe that the SPECULATIVE NEAR TERM TARGET PRICE for next 5 days - $0.19
NEWS * NEWS * NEWS * NEWS * NEWS
----------------------------------------------------------------
Coastal Holdings, Inc. in Negotiations to Acquire Interest in BioMedicom Inc.
----------------------------------------------------------------
HOUSTON , Jun 25, 2004 (PRIMEZONE via COMTEX) -- Coastal Holdings, Inc. (Pink
Sheets:CSJJ) is pleased to announce that it is in negotiations to acquire a
35%-45% equity interest in BioMedicom Inc. (BIOMED). BIOMED will be an
exhibitor at the International Congress of Radiology to be held June 27-29,
2004 at the Palais des Congres de Montreal. CSJJ CEO Andrea Cortellazzi will be
in negotiations with BIOMED CEO Michael Berman prior to the start of the
Congress in Montreal. CSJJ will announce the outcome of this meeting at a
future date. The investment in BIOMED will be for a total of $2M with an
initial deposit of $300,000 upon contract signing. As part of the investment,
CSJJ would receive distribution rights in North America to SONOReal, a
revolutionary add-on to any ultrasound system. This product makes 3D ultrasound
imaging easy to learn, use and afford. It increases the productive life of an
existing ultrasound system, enabling 3D visualization in real-time, while
maintaining familiar protocols. SONOReal has received several regulatory
clearances, notably from the ISO and the FDA.
About BioMedicom Inc. (BIOMED)
---------------
Disclaimer
---------------
Information within this email contains "forward looking statements" within the
meaning of Section 27A of the Securities Act of 1933 and Section 21B of the
Securities Exchange Act of 1934. Any statements that express or involve
discussions with respect to predictions, goals, expectations, beliefs, plans,
projections, objectives, assumptions or future events or performance are not
statements of historical fact and may be "forward looking statements."
Forward looking statements are based on expectations, estimates and projections
at the time the statements are made that involve a number of risks and
uncertainties which could cause actual results or events to differ materially
from those presently anticipated. Forward looking statements in this action may
be identified through the use of words such as: "projects", "foresee",
"expects", "estimates," "believes," "understands" "will," "part of:
"anticipates," or that by statements indicating certain actions "may," "could,"
or "might" occur. All information provided within this email pertaining to
investing, stocks, securities must be understood as information provided and
not investment advice. we advise all readers and subscribers to seek advice
from a registered professional securities representative before deciding to
trade in stocks featured within this email. None of the material within this
report shall be construed as any kind of investment advice. Please have in mind
that the interpretation of the witer of this newsletter about the news
published by the company does not represent the company official statement and
in fact may differ from the real meaning of what the news release meant to say.
Please read the news release by yourself and judge by yourself about the
details in it.
In compliance with Section 17(b), we disclose the holding of CSJJ shares prior
to the publication of this report. Be aware of an inherent conflict of interest
resulting from such holdings due to our intent to profit from the liquidation
of these shares. Shares may be sold at any time, even after positive statements
have been made regarding the above company. Since we own shares, there is an
inherent conflict of interest in our statements and opinions. Readers of this
publication are cautioned not to place undue reliance on forward-looking
statements, which are based on certain assumptions and expectations involving
various risks and uncertainties, that could cause results to differ materially
from those set forth in the forward- looking statements.
Please be advised that nothing within this email shall constitute a
solicitation or an offer to buy or sell any security mentioned herein. This
newsletter is neither a registered investment advisor nor affiliated with any
broker or dealer. All statements made are our express opinion only and should
be treated as such. We may own, buy and sell any securities mentioned at any
time. This report includes forward-looking statements within the meaning of The
Private Securities Litigation Reform Act of 1995. These statements may include
terms as "expect", "believe", "may", "will", "move","undervalued" and "intend"
or similar terms. This newsletter was paid $5500 from third party to send this
report. PLEASE DO YOUR OWN DUE DILIGENCE BEFORE INVESTING IN ANY PROFILED
COMPANY. You may lose money from investing in Penny Stocks.
rink ,sunscreen
,penelope ,beloit .
siliceous ,whistle
,lingua ,melville .
|